We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients

This study has been terminated.
(Interim analysis results revealed substantial increase of patient number, with unfeasible study prolongation.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01334892
First Posted: April 13, 2011
Last Update Posted: April 14, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Pari Pharma GmbH
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)